Case Study
Read our short case study about the results we have delivered with Cathepsin S, using our unique affinity maturation platform RAMP™
https://fusionantibodies.com/wp-content/uploads/RAMP-Case-Study-Cathepsin-S.jpg
1014
1800
mint_design
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg
mint_design2021-03-14 11:58:242022-04-05 10:45:42A Novel Approach to Affinity Maturation
https://fusionantibodies.com/wp-content/uploads/fusion-antibody-visual-05.jpg
1200
1800
Andrew Glover
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg
Andrew Glover2018-12-19 10:56:102023-04-24 15:03:07Humanized Antibody JF5 detects Aspergillus
https://fusionantibodies.com/wp-content/uploads/antibody-visual-02.jpg
1200
1800
Andrew Glover
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg
Andrew Glover2018-12-19 10:51:052023-04-24 13:27:35Potential biomarkers for bladder and colon cancer
info@fusionantibodies.com
+44 (0)28 9043 2800
Investor and Media
+44 (0)20 7933 8780
fusion@walbrookpr.com
Fusion Antibodies PLC, Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast BT17 0QL